Seeking Men & Women 18 years or older who have previously untreated stages IIB - IIIA Non-Small Cell Lung Cancer (NSCLC).
This study is being done to see if chemotherapy treatment before surgery, in combination with an investigational immunotherapy is safe and effective in slowing down or stopping the progression of cancer.
What we're hoping for
The investigational product, given with standard chemotherapy, may lead the cancer to shrink or grow more slowly than if patient would receive chemotherapy alone. After surgery, it may decrease the chances of the cancer coming back.
ClinicalTrials.gov Identifier: NCT03425643